Table 3 Rates of responses in different sexes, ages, genotypes, treatment types and viral titres (N = 136)
Factor | Total Treated | RVR (%) | EVR (%) | BTR (%) | ETR (%) | NR (%) | SVR (%) |
|---|---|---|---|---|---|---|---|
SEX | |||||||
Male Female | 69 67 | 3(4.3) 2(2.9) | 7(10.1) 6(8.9) | 4(5.8) 6(8.9) | 52(75.4) 48(71.6) | 17(24.6) 19(28.3) | 48(69.6) 33(49.3) |
AGE-years | |||||||
<20 | 6 | 0 | 0 | 0 | 5(83.3) | 1(16.7) | 4(66.7) |
21-30 | 42 | 1(2.4) | 4(9.5) | 2(4.8) | 35(83.3) | 7(16.7) | 32(76.2) |
31-40 | 43 | 2(4.7) | 6(13.9) | 5(11.6) | 28(65.1) | 15(34.9) | 21(48.8) |
41-50 | 36 | 2(5.6) | 2(5.6) | 2(5.6) | 27(75) | 9(25) | 19(52.8) |
51-60 & above | 9 | 0 | 1(11.1) | 1(11.1) | 5(55.6) | 4(44.4) | 4(44.4) |
GENOTYPE | |||||||
None-1 | 124 | 5(4) | 12(9.7) | 9(7.3) | 92(74.2) | 32(25.8) | 74(59.7) |
1 & Mixed | 12 | 0 | 1(8.3) | 1(8.3) | 8(66.7) | 4(33.3) | 7(58.3) |
TREATMENT | |||||||
INF+RBV | 86 | 4(4.7) | 8(9.3) | 10(11.6) | 60(69.8) | 26(30.2) | 46(53.5) |
PEGINF+RBV | 50 | 1(2) | 5(10) | 0 | 40(80) | 10(20) | 35(70) |
PRE-TREATMEN | |||||||
VIRAL LOAD | |||||||
<200 IU/mL | 112 | 4(3.6) | 13(11.6) | 9(8) | 81(72.3) | 31(27.7) | 65(58) |
>200 IU/mL | 24 | 1(4.2) | 0 | 1(4.2) | 19(79.1) | 5(20) | 16(66.7) |
TOTAL | 136 | 5(3.6) | 13(9.6) | 10(7.4) | 100(73.5) | 36(26.5) | 81(59.6) |